These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15201806)

  • 1. Monitoring the serological proteome: the latest modality in prostate cancer detection.
    Mobley JA; Lam YW; Lau KM; Pais VM; L'Esperance JO; Steadman B; Fuster LM; Blute RD; Taplin ME; Ho SM
    J Urol; 2004 Jul; 172(1):331-7. PubMed ID: 15201806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic potential of serum proteomic patterns in prostate cancer.
    Bañez LL; Prasanna P; Sun L; Ali A; Zou Z; Adam BL; McLeod DG; Moul JW; Srivastava S
    J Urol; 2003 Aug; 170(2 Pt 1):442-6. PubMed ID: 12853795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 ng/ml.
    Ornstein DK; Rayford W; Fusaro VA; Conrads TP; Ross SJ; Hitt BA; Wiggins WW; Veenstra TD; Liotta LA; Petricoin EF
    J Urol; 2004 Oct; 172(4 Pt 1):1302-5. PubMed ID: 15371828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer.
    Lam YW; Mobley JA; Evans JE; Carmody JF; Ho SM
    Proteomics; 2005 Jul; 5(11):2927-38. PubMed ID: 15952230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
    Liu XP; Shen J; Li ZF; Yan L; Gu J
    Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digitized serum mass spectrometry peaks diagnostic of prostate cancer.
    Cancer Biol Ther; 2004 Jul; 3(7):585. PubMed ID: 15751161
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men.
    Adam BL; Qu Y; Davis JW; Ward MD; Clements MA; Cazares LH; Semmes OJ; Schellhammer PF; Yasui Y; Feng Z; Wright GL
    Cancer Res; 2002 Jul; 62(13):3609-14. PubMed ID: 12097261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility.
    Semmes OJ; Feng Z; Adam BL; Banez LL; Bigbee WL; Campos D; Cazares LH; Chan DW; Grizzle WE; Izbicka E; Kagan J; Malik G; McLerran D; Moul JW; Partin A; Prasanna P; Rosenzweig J; Sokoll LJ; Srivastava S; Srivastava S; Thompson I; Welsh MJ; White N; Winget M; Yasui Y; Zhang Z; Zhu L
    Clin Chem; 2005 Jan; 51(1):102-12. PubMed ID: 15613711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 17-protein signature in the serum of lung cancer patients.
    Sreseli RT; Binder H; Kuhn M; Digel W; Veelken H; Sienel W; Passlick B; Schumacher M; Martens UM; Zimmermann S
    Oncol Rep; 2010 Jul; 24(1):263-70. PubMed ID: 20514471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
    Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
    Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
    Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry.
    Hara T; Honda K; Ono M; Naito K; Hirohashi S; Yamada T
    J Urol; 2005 Oct; 174(4 Pt 1):1213-7. PubMed ID: 16145372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers.
    Soltys SG; Le QT; Shi G; Tibshirani R; Giaccia AJ; Koong AC
    Clin Cancer Res; 2004 Jul; 10(14):4806-12. PubMed ID: 15269156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.
    Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; Yang BX; He DC; Zhao XJ
    Asian J Androl; 2006 Jan; 8(1):45-51. PubMed ID: 16372118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry.
    Engwegen JY; Helgason HH; Cats A; Harris N; Bonfrer JM; Schellens JH; Beijnen JH
    World J Gastroenterol; 2006 Mar; 12(10):1536-44. PubMed ID: 16570345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population.
    Chen YD; Zheng S; Yu JK; Hu X
    Clin Cancer Res; 2004 Dec; 10(24):8380-5. PubMed ID: 15623616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved signal processing and normalization for biomarker protein detection in broad-mass-range TOF mass spectra from clinical samples.
    Tracy MB; Cooke WE; Gatlin CL; Cazares LH; Weaver DM; Semmes OJ; Tracy ER; Manos DM; Malyarenko DI
    Proteomics Clin Appl; 2011 Aug; 5(7-8):440-7. PubMed ID: 21751409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classification and diagnostic prediction of colorectal cancer using protein profiling of serum and bioinformatics].
    Chen YD; Xie PP; Yu JW; Zhou J; Zheng S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 38(5):470-7. PubMed ID: 19830859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.